Company profile for Spyre Therapeutics

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Spyre Therapeutics is dedicated to developing cutting-edge antibodies, strategic therapeutic combinations, and precise immunology techniques aimed at producing Inflammatory Bowel Disease (IBD) treatments that offer unparalleled effectiveness and convenience.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
Waltham, MA 02453
Telephone
Telephone
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Natural Product Expo West

Natural Product Expo West

Not Confirmed

envelop Contact Supplier

Natural Product Expo West

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2026/02/24/3244017/0/en/Spyre-Therapeutics-to-Participate-in-Upcoming-March-Investor-Conferences.html

GLOBENEWSWIRE
24 Feb 2026

https://www.globenewswire.com/news-release/2026/02/19/3241518/0/en/Spyre-Therapeutics-Reports-Fourth-Quarter-and-Full-Year-2025-Financial-Results-and-Provides-Corporate-Update.html

GLOBENEWSWIRE
19 Feb 2026

https://www.globenewswire.com/news-release/2026/02/18/3240150/0/en/Spyre-Therapeutics-Announces-Presentations-at-the-21st-ECCO-Congress-Supporting-Differentiated-Profile-of-SPY003-and-Novel-Animal-Studies-Demonstrating-Superiority-of-Combination-A.html

GLOBENEWSWIRE
18 Feb 2026

https://www.globenewswire.com/news-release/2026/02/06/3234069/0/en/Spyre-Therapeutics-Announces-Grants-of-Inducement-Awards.html

GLOBENEWSWIRE
06 Feb 2026

https://www.globenewswire.com/news-release/2026/01/23/3225057/0/en/Spyre-Therapeutics-Announces-Grants-of-Inducement-Awards.html

GLOBENEWSWIRE
23 Jan 2026

https://www.globenewswire.com/news-release/2026/01/12/3216806/0/en/Spyre-Therapeutics-Poised-for-Transformational-2026-With-Six-Expected-Proof-of-Concept-Readouts-Beginning-in-Q2.html

GLOBENEWSWIRE
12 Jan 2026

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty